OPKO Health, Inc., 10% Owner at Sorrento Therapeutics, Inc. (SRNE), sold 13,457 shares at $8.75 ($118K) on 2013-11-13, disclosed to the SEC on 2013-11-14.
Open-market sale of $118k SRNE by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| Filing → |
| WGS | SELL | 2024-08-08 | $3.9M | — | Filing → |
| WGS | SELL | 2024-08-02 | $6.0M | — | Filing → |
| WGS | SELL | 2024-07-31 | $1.7M | — | Filing → |